Skip to content

Lodoxamide

Mast Cell Stabilizer — SENSORY ORGANS

Also known as: alomide, lodoxamide trometamol, lodoxamide tromethamine, U 42585E, U-42,585E

OfmFDA approvedOrphan designationATC S01GX05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Lodoxamide is an ofm drug in the Mast Cell Stabilizer class catalogued in DrugCentral. It was first approved by the FDA in 1993. DrugCentral lists 1 molecular target, including GPR35. Recorded indications include Vernal conjunctivitis, Vernal Keratitis and Vernal keratoconjunctivitis.

  • Approval status: ofm (first approved 1993 by the FDA).
  • Drug class: Mast Cell Stabilizer.
  • Molecular targets: GPR35 (1 listed in DrugCentral).
  • Indications: Vernal conjunctivitis, Vernal Keratitis and Vernal keratoconjunctivitis.
  • ATC code: S01GX05 (Other antiallergics).
  • Molecular formula: C11H6ClN3O6; molecular weight 311.64 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Vernal conjunctivitis
  • Vernal Keratitis
  • Vernal keratoconjunctivitis

Off-label uses (3)

  • Allergic conjunctivitis
  • Allergic Keratoconjunctivitis
  • Giant papillary conjunctivitis

Mechanism & targets

Established pharmacologic classMast Cell Stabilizer

Molecular targets (1)

TargetGeneActionActivity
G-protein coupled receptor 35GPR35agonistEC50 8.79

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1993-09-23FDA—ALCONYes

ATC classification

ATC codeTherapeutic hierarchy
S01GX05SENSORY ORGANS › OPHTHALMOLOGICALS › DECONGESTANTS AND ANTIALLERGICS › Other antiallergics

Chemical structure

Molecular formulaC11H6ClN3O6
Molecular weight311.64 g/mol
CAS number—
InChIKeyRVGLGHVJXCETIO-UHFFFAOYSA-N
PubChem CID44564
OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Lodoxamide used for?

DrugCentral lists the following indications for Lodoxamide: Vernal conjunctivitis, Vernal Keratitis and Vernal keratoconjunctivitis.

How does Lodoxamide work?

Its molecular targets in DrugCentral include GPR35 (agonist).

When was Lodoxamide first approved?

Lodoxamide was first approved by the FDA in 1993.

What drug class does Lodoxamide belong to?

Lodoxamide is in the Mast Cell Stabilizer class.

What is the chemical formula of Lodoxamide?

Lodoxamide has the molecular formula C11H6ClN3O6 and a molecular weight of 311.64 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1993-09-23
AgencyFDA
Targets1
Indications3
FormulaC11H6ClN3O6
DrugCentral ID3325
Interactive profile